| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/05/2012 | CA2823138A1 Sirna for inhibition of hif1a expression and anticancer composition containing the same |
| 07/05/2012 | CA2822176A1 Small molecule conjugates for intracellular delivery of biologically active compounds |
| 07/05/2012 | CA2822161A1 Small molecule conjugates for intracellular delivery of nucleic acids |
| 07/04/2012 | EP2470657A2 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 07/04/2012 | EP2470652A1 Ercc6l as target genes for cancer therapy and diagnosis |
| 07/04/2012 | EP2470650A1 Breast cancer related gene c12orf32 |
| 07/04/2012 | EP2470250A1 Optimized placement of cannula for delivery of therapeutics to the brain |
| 07/04/2012 | EP2470217A1 Targeting pax2 for the treatment of breast cancer |
| 07/04/2012 | EP1883699B1 Non-viral vector system for transporting nucleic acid into the lungs |
| 07/04/2012 | CN1918284B Stem cells |
| 07/04/2012 | CN1882687B Method of growing myocardial cells |
| 07/04/2012 | CN1816280B Dermal micro organs, methods and apparatuses for producing and using the same |
| 07/04/2012 | CN102549159A Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1 |
| 07/04/2012 | CN102549158A Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3 |
| 07/04/2012 | CN102548584A Oncolytic adenoviruses for treating cancer |
| 07/04/2012 | CN102534003A Applications of human pre-B-cell leukemia homeobox 1 (PBX1) gene and related drugs thereof |
| 07/04/2012 | CN102533982A New use of human gene KLF8 in tumor treatment |
| 07/04/2012 | CN102533972A IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 07/04/2012 | CN102533966A Micro-RNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
| 07/04/2012 | CN102533860A Foot and mouth disease vaccine and preparation method thereof |
| 07/04/2012 | CN102533859A Adenovirus vector carrying inducible co-stimulater gene, and construction method and application of adenovirus vector |
| 07/04/2012 | CN102533858A Tumor-specific replication-competent adenovirus anti-tumor preparation |
| 07/04/2012 | CN102533855A Gene-vector composition of targeted microglia as well as preparation method and application of gene-vector composition |
| 07/04/2012 | CN102533830A Immune gene therapy plasmid cooperatively expressed by alpha fetal protein (AFP) epitope peptide and IL-15 |
| 07/04/2012 | CN102533828A Recombinant plasmid and virus of tissue specificity and application thereof. |
| 07/04/2012 | CN102533823A Antiviral preparation with HSV (Herpes Simplex Virus) amplicon as carrier |
| 07/04/2012 | CN102533798A Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof |
| 07/04/2012 | CN102533770A Nucleic acid molecule and application thereof |
| 07/04/2012 | CN102533763A Construction and use of lentivirus-mediated siRNA (small interfering RNA) recombinant 970 against VEGF-C (vascular endothelial growth factor C) gene |
| 07/04/2012 | CN102533755A Human miR-328 antisense nucleic acid and application thereof |
| 07/04/2012 | CN102533668A Duck flavivirus, and vaccine and kit thereof |
| 07/04/2012 | CN102533661A Human embryonic stem cell-derived endothelial cell from with functions of tumor targeting, in-vivo tracking and tumor treating |
| 07/04/2012 | CN102532326A Tumor-targeted plasminogen Kringle5 variant and application thereof |
| 07/04/2012 | CN102532259A Oligopeptide-based cationic lipid derivative and application thereof in pharmaceutical preparation |
| 07/04/2012 | CN102526763A Application of geranylgeranyl diphosphate synthase (GGPPS) antagonist in preparation of medicament for treating II-type diabetes mellitus |
| 07/04/2012 | CN102526762A Application of ALC1 to preparation of leukaemia drug resistance reversing agent and as drug-resistant leukaemia diagnosing reagent |
| 07/04/2012 | CN102526761A DNA vaccine for treating hepatic fibrosis caused by Schistosomiasis japonica and application thereof |
| 07/04/2012 | CN102526760A Recombinant attenuated salmonella vaccine and pharmaceutical composition for treating solid tumors and application thereof |
| 07/04/2012 | CN102526718A Recombinant H5N1 (Hemagglutinin 5 Neuraminidase 1) avian influenza virus cell vaccine and application thereof |
| 07/04/2012 | CN102525926A Propylene glycol amine derivate cationic liposome nano particles and preparation method thereof |
| 07/04/2012 | CN102525882A Nanocomposite temperature-sensitive gel and preparation method and application thereof |
| 07/04/2012 | CN102181457B Clostridium difficile exotoxin B amino-terminal gene sequence with optimized codon and nucleic vaccine of clostridium difficile exotoxin B |
| 07/04/2012 | CN102153650B Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 07/04/2012 | CN102153649B Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 07/04/2012 | CN102153648B EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 07/04/2012 | CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 07/04/2012 | CN102121023B Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/04/2012 | CN101991862B Cyclodextrin-polyethyleneimine-mediated supramolecular delivery system and preparation method |
| 07/04/2012 | CN101955956B Eimeria tenella calcium-dependent protein kinase gene and application thereof |
| 07/04/2012 | CN101955545B Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
| 07/04/2012 | CN101948834B siRNA for treating HBV |
| 07/04/2012 | CN101899096B Blood group A epitope mimic peptide and application thereof |
| 07/04/2012 | CN101884792B Immune enhanced gene vaccine of hepatitis B virus surface antigen and preparation method thereof |
| 07/04/2012 | CN101875695B Antibody, and coding gene and application thereof |
| 07/04/2012 | CN101850116B Method for constructing virus live vector recombinant vaccine by utilizing transposon |
| 07/04/2012 | CN101824434B Antigen presenting cell, preparation method thereof and application thereof |
| 07/04/2012 | CN101812178B Reduction sensitive polyethyleneimine derivative as well as preparation method and application thereof |
| 07/04/2012 | CN101804209B PEDF (Pigment Epithelial Derived Factor) gene PLGA nano compound as well as preparation method and use thereof |
| 07/04/2012 | CN101798349B Anti-uPAR humanized antibody and coding gene thereof |
| 07/04/2012 | CN101503437B Nucleic acid molecule SI-CYPJ-4 and use thereof in anti-cancer medicine preparation |
| 07/04/2012 | CN101491536B Therapeutically useful synthetic oligonucleotides |
| 07/04/2012 | CN101480489B Novel uses of plasmodium circumsporozoite protein in resisting proliferation and migration of tumor |
| 07/04/2012 | CN101422604B Immunoloregulation type DNA vaccine capable of preventing Eimeria acervulina |
| 07/04/2012 | CN101396556B Immunoregulation DNA vaccine capable of preventing chicken Eimeria maxima |
| 07/04/2012 | CN101346155B Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues |
| 07/04/2012 | CN101333237B Oligonucleotide with breast carcinoma treating function |
| 07/04/2012 | CN101001615B Drug delivery product and methods |
| 07/03/2012 | US8212019 Nucleic acid silencing sequences |
| 07/03/2012 | US8212017 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer |
| 07/03/2012 | US8211868 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 07/03/2012 | US8211866 Methods and compositions for treating HIV infection |
| 07/03/2012 | US8211865 Inhibition of ornithine aminotransferase for the treatment of proliferative disorders |
| 07/03/2012 | US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor |
| 07/03/2012 | US8211426 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 07/03/2012 | US8211422 Comprising a first gene segment encoding a single-chain Fv domain (scFv) of a specific antibody and a second gene segment encoding partially or entirely the transmembrane and cytoplasmic domains; gene therapy; antitumor agents |
| 07/03/2012 | US8211421 Mutant having uracil phosphoribosyl transferase activity |
| 07/03/2012 | CA2640956C B7rp-1 polypeptides |
| 07/03/2012 | CA2563264C Connexin 40 tissue specific gene mutations |
| 07/03/2012 | CA2463631C Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 07/03/2012 | CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/03/2012 | CA2446968C Human artificial chromosome containing human antibody .lambda. light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 07/03/2012 | CA2445577C Subcellular targeting of therapeutic proteins |
| 07/03/2012 | CA2305269C Treatment of neoplasms with viruses |
| 06/28/2012 | WO2012088434A2 Compositions relating to a phosphoprotein and methods of use |
| 06/28/2012 | WO2012088067A1 Methods for predicting and/or determining responsiveness to a histone deacetylase (hdac) inhibitor |
| 06/28/2012 | WO2012088001A2 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus |
| 06/28/2012 | WO2012087242A1 Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138 |
| 06/28/2012 | WO2012086474A1 Therapeutic agent for central nervous system diseases |
| 06/28/2012 | WO2012085622A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses |
| 06/28/2012 | WO2012085318A1 Lipid nanoparticles for treating ocular diseases |
| 06/28/2012 | WO2012083363A1 A method of treatment |
| 06/28/2012 | WO2012047339A9 Anti-cxcr4 as a sensitizer to cancer therapeutics |
| 06/28/2012 | WO2012031137A3 Vesicular stomatitis viruses |
| 06/28/2012 | WO2011126808A3 Pharmacologically induced transgene ablation system |
| 06/28/2012 | US20120165400 Gene repair involving in vivo excision of targeting dna |
| 06/28/2012 | US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/28/2012 | US20120165262 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 06/28/2012 | US20120164212 Stem cell beacon |
| 06/28/2012 | US20120164173 Papilloma Pseudovirus and Preparation |
| 06/28/2012 | US20120164154 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes |